Contrast‐enhanced ultrasonography using cadence‐contrast pulse sequencing technology for targeted biopsy of the prostate
- 2 February 2009
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 103 (4), 458-463
- https://doi.org/10.1111/j.1464-410x.2008.08038.x
Abstract
To evaluate contrast-enhanced ultrasonography (US) using cadence-contrast pulse sequencing (CPS) technology, compared with systematic biopsy for detecting prostate cancer, as grey-scale US has low sensitivity and specificity for detecting prostate cancer. In all, 44 men with suspicious prostate-specific antigen (PSA) levels and CPS findings were assessed; all had CPS-targeted and systematic biopsy. Transrectal CPS images were taken with a low mechanical index (0.14). A microbubble contrast agent (SonoVue, Bracco International BV, Amsterdam, the Netherlands) was administered as a bolus, with a maximum dose of 4.8 mL. CPS was used to assess prostatic vascularity. Areas with a rapid and increased contrast enhancement within the peripheral zone were defined as suspicious for prostate cancer. Up to five CPS targeted biopsies were taken and subsequently a 10-core systematic biopsy was taken. Cancer detection rates for the two techniques were compared. Overall, cancer was detected in 35 of 44 patients (80%), with a mean PSA level of 3.8 ng/mL. Lesions suspicious on CPS showed cancer in 35 of 44 patients (80%) and systematic biopsy detected cancer in 15 of 44 patients (34%). CPS-targeted cores were positive in 105 of 220 cores (47.7%) and in 41 of 440 systematic biopsy cores (9.3%) (P < 0.001). Lesions suspicious on CPS were false-positive in nine of 44 patients (20%). The mean Gleason score for systematic biopsy was 6.7 and for CPS-targeted biopsy 6.8 (P > 0.05). The sensitivity of CPS for detecting cancer was 100% (confidence interval, 95%). However, limitations in the series included that only CPS-positive cases were investigated, and CPS-targeted biopsy should be evaluated in a more extended biopsy scheme. Contrast-enhanced US using CPS enables excellent visualization of the microvasculature associated with prostate cancer, and can improve the detection of prostate cancer compared with systematic biopsy.Keywords
This publication has 34 references indexed in Scilit:
- Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong directionBJU International, 2008
- Early Detection of Prostate Cancer in 2007: Part 1: PSA and PSA KineticsEuropean Urology, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Contrast ultrasound imaging: the best method to detect type II endoleak during endovascular aneurysm repair follow-up☆Interactive CardioVascular and Thoracic Surgery, 2007
- Contrast-enhanced ultrasonography in the follow-up of cryoablation of renal tumours: a feasibility studyBJU International, 2007
- Low-MI-Sonographie mit dem Ultraschallkontrastmittel SonoVue im Vergleich zur Computertomographie bei Organinfarkten und Nekrosen in Milz, Niere, Leber und PankreasUltraschall in der Medizin - European Journal of Ultrasound, 2006
- Are Transition Zone Biopsies Still Necessary to Improve Prostate Cancer Detection?: Results from the Tyrol Screening ProjectEuropean Urology, 2005
- Evaluation of Cerebral Perfusion Deficit in Stroke Patients Using New Transcranial Contrast Imaging CPS™ Technology - Preliminary ResultsUltraschall in der Medizin - European Journal of Ultrasound, 2005
- PROSPECTIVE EVALUATION OF LATERAL BIOPSIES OF THE PERIPHERAL ZONE FOR PROSTATE CANCER DETECTIONJournal of Urology, 1998
- Echogenic structure of prostatic cancer imaged on radical prostatectomy specimensThe Prostate, 1987